Hepatitis C Virus (HCV) NS3 Sequence Diversity and Antiviral Resistance-Associated Variant Frequency in HCV/HIV Coinfection

HIV coinfection accelerates disease progression in chronic hepatitis C and reduces sustained antiviral responses (SVR) to interferon-based therapy. New direct-acting antivirals (DAAs) promise higher SVR rates, but the selection of preexisting resistance-associated variants (RAVs) may lead to virolog...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Jabara, Cassandra B., Hu, Fengyu, Mollan, Katie R., Williford, Sara E., Menezes, Prema, Yang, Yan, Eron, Joseph J., Fried, Michael W., Hudgens, Michael G., Jones, Corbin D., Swanstrom, Ronald, Lemon, Stanley M.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2014
Teme:
Antiviral Agents
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4187920/
https://ncbi.nlm.nih.gov/pubmed/25092699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03466-14
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items